Home/Filings/4/0001493152-25-012689
4//SEC Filing

Chuang Emil 4

Accession 0001493152-25-012689

CIK 0001357459other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 9:00 AM ET

Size

16.6 KB

Accession

0001493152-25-012689

Insider Transaction Report

Form 4
Period: 2025-09-04
Chuang Emil
Director
Transactions
  • Award

    Phantom Units

    2025-09-04+18,80018,800 total
    Common Stock (18,800 underlying)
Footnotes (3)
  • [F1]Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.
  • [F2]The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.
  • [F3]Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date.

Issuer

PALISADE BIO, INC.

CIK 0001357459

Entity typeother

Related Parties

1
  • filerCIK 0001921045

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 9:00 AM ET
Size
16.6 KB